4//SEC Filing
POTTI RAM 4
Accession 0001053369-13-000025
CIK 0001053369other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 6:13 PM ET
Size
12.4 KB
Accession
0001053369-13-000025
Insider Transaction Report
Form 4
POTTI RAM
Director10% Owner
Transactions
- Other
Warrants
2013-03-25−6,666,667→ 2,436,665 total(indirect: see footnote)Exercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (6,666,667 underlying) - Conversion
Common Stock
2013-03-21+15,946,502→ 29,027,142 total(indirect: see footnote) - Other
Common Stock
2013-03-25$0.04/sh−13,550,136$500,000→ 15,477,006 total(indirect: see footnote) - Conversion
Series E Convertible Preferred Stock
2013-03-21$1000.00/sh−387.5$387,500→ 1,800 total(indirect: see footnote)Exercise: $0.02From: 2013-03-21→ Common Stock (15,946,502 underlying)
Footnotes (7)
- [F1]Ram Potti is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer.
- [F2]Conversion of Series E Preferred Stock of issuer at the rate of approximately 41,152.26 shares of common for each share of such preferred stock.
- [F3]Of the 29,027,142 shares of common stock, 28,610,803 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person.
- [F4]Of the 15,477,006 shares of common stock, 15,060,667 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person.
- [F5]Disposition of shares to its members
- [F6]Disposition of warrants to its members
- [F7]N/A
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001465824
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 6:13 PM ET
- Size
- 12.4 KB